Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
OSL Announcements
OncoSil Selected for Major European…
OSL
ONCOSIL MEDICAL LTD
Market sensitive
OncoSil Selected for Major European Pancreatic Cancer Study
Date and time
2 July 2026 at 6:46 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
OSL announcement history
Recent OSL announcements
Change in substantial holding
Change in substantial shareholding from AEF
Application for quotation of securities - OSL
Investor Webinar Presentation
OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
Quarterly Activities/Appendix 4C Cash Flow Report